Panacea Biotec Shares Soar 9% on Phase III Trial for DengiALL
Shares of Panacea Biotec Ltd soared 9% on 8 January after the company announced that enrollment in the Phase III clinical trial of DengiALL, its...
Tag : Phase III trial
Wockhardt Looking to Complete Phase III Trials for Zaynich
The Indian pharma company, Wockhardt Ltd, on Wednesday, 29 May, said that the Phase III clinical trial for Zaynich (Zidebactam/Cefepime) is expected to be completed...